- Report
- March 2025
- 86 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- October 2024
- 184 Pages
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 189 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 196 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- July 2025
Global
From €4279EUR$4,900USD£3,717GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1092EUR$1,250USD£948GBP
- Report
- September 2025
- 180 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 282 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 183 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- April 2025
- 200 Pages
Global
From €6943EUR$7,950USD£6,031GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1310EUR$1,500USD£1,138GBP
- Report
- March 2025
- 145 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- June 2025
- 200 Pages
Global
From €2436EUR$2,789USD£2,116GBP
- Report
- April 2023
- 137 Pages
Global
From €6550EUR$7,500USD£5,690GBP
- Report
- May 2024
- 133 Pages
Global
From €5676EUR$6,499USD£4,931GBP

Ifosfamide is an oncology drug used to treat a variety of cancers, including testicular, ovarian, bladder, and lung cancer. It is a prodrug, meaning it is converted to its active form in the body. It works by inhibiting the growth of cancer cells and inducing apoptosis, or programmed cell death. It is usually administered intravenously, and is often used in combination with other drugs. Common side effects include nausea, vomiting, and hair loss.
Ifosfamide is a generic drug, and is available from a variety of manufacturers. Some of the companies in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Show Less Read more